(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QIACUBE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QIACUBE

ST13

US500000079037735

Class

1, 5, 9, 42

Filing

79037735

Registration

3445464

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

07/30/2026

Trademark type

Word

Nice classes

1, 5, 9, 42

Filing date

08/28/2006

Registration date

06/10/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/06/2018

Last transaction

07/30/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

40724 Hilden, DE

Examiner

SETTLES LEWIS, SHAILA E

Law office

M50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

QIAGEN GmbH

Representatives

Victoria Friedman Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 1Class 5Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biotechnological products for industrial and scientific purposesin particular nucleic acidsenzymespolymerasesreagents for staining and markingmolecular probesbufferaqueous and non-aqueous solutions of alcohols and saltsdistilled and purified watersilica in powderedgranulate and gel form and magnetic particles in fluid formnone of the foregoing for medical or veterinary purposes; Materials for columns and reagents and solvents for sample preparationall of the foregoing for the purpose of purificationlysismodification and manipulation of cellsas well as for the performance of markingseparationisolationpurificationamplification and analytical methods for biopolymersin particular nucleic acidsenzymesproteinsmacro molecules and biologically active substances for separationanalysis and purification of biological and biochemical compoundsnone of the foregoing for medical or veterinary purposes; Kits comprising chemicalbiochemical and biotechnological products for sample preparationpurificationlysismodification and manipulation of cells as well as for the performance of markingseparationisolationpurificationamplification and analytical methods for biopolymersin particular nucleic acidsenzymesproteinsmacro molecules and biologically active substances for separationanalysis and purification of biological and biochemical compoundsin particular nucleic acids made from biological and biochemical sample materialnone of the foregoing for medical or veterinary purposes

Class 5

Products for medical and veterinary medical purposesin particular diagnostic preparationsin particular nucleic acidsenzymespolymerasesreagents for staining and markingmolecular probesbuffer chemicals and aqueous and non-aqueous solutions of primarysecondary and tertiary alcohols and saltsdistilled and purified watermagnetic particles in fluid formmaterials for columns for the purpose of purificationlysismodification and manipulation of cellsas well as for the performance of markingseparationisolationpurificationamplification and analytical methods for biopolymersin particular nucleic acidsenzymesproteinsmacro molecules and biologically active substances for separationanalysis and purification of biological and biochemical compoundsall of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposeschemicalbiochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposesin particular chemicalbiochemical and biotechnological products for sample preparationpurificationlysismodification and manipulation of cellsas well as for the performance of markingseparationisolationpurificationamplification and analytical methods for biopolymersin particular nucleic acids for medical and veterinary medical purposesenzymesnatural and artificial proteinsmacro moleculesbiologically active substances for detecting pathogensgenetic information and conditions of the human body

Class 9

Scientific apparatusinstruments and equipment for research and examination purposeslaboratory equipmentchromatography columns; automated laboratory equipmentrobots and spare parts and add-ons thereforpreprogrammed smart cards for DNA purification protocols; laboratory equipmentmicroplates; laboratory equipmentpipettespipette tips and pipette tip holders; laboratory equipmentsample containersreagent holdersflasksreagent tube holdersholders for micro containersmagnetic syringesbiochips for the purpose of screen large numbers of biological analytesthermocyclers for the purpose of performing polymerase chain reactionshomogenizers for the purpose of breaking up cell membranes and mixing the resulting liquidsvacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressureall of the aforementioned being included in this class and being for scientific research and examination purposes

Class 42

Scientific research for others in the fields of chemistrygeneticsbiology and biochemistry; Scientific diagnostic services for others in the fields of DNARNA and protein detection and analysis; Research services in the field of forensic scienceanalysisdetection and isolation of biological substances in forensic samples

Publications

History of USPTO decisions and trademark events.

46 publications found

RNWL

INTERNATIONAL REGISTRATION RENEWED

07/30/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

02/13/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

02/06/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/06/2018

71AG

REGISTERED-SEC.71 ACCEPTED

06/06/2018

ES71

TEAS SECTION 71 RECEIVED

05/31/2018

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/10/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

09/15/2016

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

07/31/2015

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

07/10/2015

INPC

INVALIDATION PROCESSED

07/10/2015

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/08/2015

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/08/2014

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

07/08/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/24/2014

ES75

TEAS SECTION 71 & 15 RECEIVED

06/04/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/30/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/14/2009

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/14/2009

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/29/2008

FIMP

FINAL DISPOSITION PROCESSED

09/29/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/10/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

06/10/2008

PUBO

PUBLISHED FOR OPPOSITION

03/25/2008

NPUB

NOTICE OF PUBLICATION

03/05/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/20/2008

ALIE

ASSIGNED TO LIE

02/20/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/18/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

01/14/2008

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/14/2008

GNEA

EXAMINERS AMENDMENT E-MAILED

01/14/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/14/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/21/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2007

FAXX

FAX RECEIVED

12/17/2007

RFNT

REFUSAL PROCESSED BY IB

07/20/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/18/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/18/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/28/2007

RFRR

REFUSAL PROCESSED BY MPU

06/28/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/28/2007

CNRT

NON-FINAL ACTION WRITTEN

06/27/2007

DOCK

ASSIGNED TO EXAMINER

06/08/2007

NWAP

NEW APPLICATION ENTERED

06/08/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/07/2007

Continuous trademark protection

Get notified about every new filing that threatens QIACUBE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.